Mycota cream

País: Reino Unido

Idioma: inglés

Fuente: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredientes activos:

Zinc undecenoate; Undecenoic acid

Disponible desde:

Thornton & Ross Ltd

Código ATC:

D01AE20

Designación común internacional (DCI):

Zinc undecenoate; Undecenoic acid

Dosis:

200mg/1gram ; 50mg/1gram

formulario farmacéutico:

Cutaneous cream

Vía de administración:

Cutaneous

clase:

No Controlled Drug Status

tipo de receta:

Valid as a prescribable product

Resumen del producto:

BNF: 13100200; GTIN: 5011309893014

Información para el usuario

MYCOTA CREAM 25G

Ficha técnica

OBJECT 1
MYCOTA CREAM
Summary of Product Characteristics Updated 08-Oct-2020 | Thornton &
Ross Ltd
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Mycota Cream
2. Qualitative and quantitative composition
Zinc Undecylenate Ph. Eur. 20.0% w/w
Undecylenic Acid Ph. Eur. 5.0% w/w
Excipient(s) with known effect:
Perfume Compound 11899 Narom (Contains Euganol) HSE 0.2% w/w
Emulsifying Wax (Contains Cetostearyl alcohol and Sodium
laurilsulfate) BP 15.0 % w/w
For full list of excipients, see section 6.1
3. Pharmaceutical form
Cream for topical administration
4. Clinical particulars
4.1 Therapeutic indications
For the treatment and prevention of athlete's foot
4.2 Posology and method of administration
ADULTS, CHILDREN AND ELDERLY
TREATMENT
Each night and morning wash thoroughly dry the foot, then smooth the
cream on to the affected area.
Take particular care to ensure the cream is massaged between the toes
then dust with Mycota Powder.
Wear clean socks or stockings each day dusted